Clinical

Dataset Information

0

Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colorectal cancer


ABSTRACT: See https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-capecitabine-with-or-without-bevacizumab-for-colorectal-cancer

DISEASE(S): Colorectal Cancer-adjuvant Therapy,Adjuvant Treatment Of Colorectal Cancer,Colorectal Cancer,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Histologically Proven Stage Iii (stage T2, T3 Or T4) And Stage Ii (any One Or More Of The Following – Stage T4, Lymphatic Invasion, Vascular Invasion, Peritoneal Involvement, Poor Differentiation) Colon Cancer (expected Ratio 70%:30%). N.b Patients Can Be Stage Ii, T3 As Long As They Have One Of The Other Poor Prognostic Features.

PROVIDER: 2417882 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2420397 | ecrin-mdr-crc
| 2418700 | ecrin-mdr-crc
| 2420357 | ecrin-mdr-crc
| 2425724 | ecrin-mdr-crc
| 2420361 | ecrin-mdr-crc
| 2424656 | ecrin-mdr-crc
| 2426817 | ecrin-mdr-crc
| 2415228 | ecrin-mdr-crc
| 2423094 | ecrin-mdr-crc
| 2410037 | ecrin-mdr-crc